Characterizing Enterovirus 71 and Coxsackievirus A16 virus-like particles production in insect cells

Methods

Volumn 95, Issue , 2016, Pages 38-45

  Somasundaram, Balaji ^a   Chang, Cindy ^a   Fan, Yuan Y ^a   Lim, Pei Yin ^b   Cardosa, Jane ^b   Lua, Linda ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b SCHOOL OF PHYSICS   (Malaysia)

Author keywords

Enterovirus; Field flow fractionation; Insect cell; Vaccine; Virus like particle

Indexed keywords

COXSACKIEVIRUS A16 VIRUS LIKE PARTICLE VACCINE; ENTEROVIRUS 71 VIRUS LIKE PARTICLE VACCINE; UNCLASSIFIED DRUG; VIRUS LIKE PARTICLE VACCINE; VIRUS ANTIBODY; VIRUS VACCINE;

ANALYTIC METHOD; ANIMAL CELL; ANTIBODY DETECTION; ARTICLE; ASYMMETRIC FLOW FIELD FLOW FRACTIONATION COUPLE WITH MULTI ANGLE LIGHT SCATTERING; BACULOVIRIDAE; CONCENTRATION (PARAMETERS); COXSACKIEVIRUS A16; DRUG SYNTHESIS; ENTEROVIRUS 71; INCUBATION TEMPERATURE; INSECT CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SPODOPTERA FRUGIPERDA; TRANSMISSION ELECTRON MICROSCOPY; TRICHOPLUSIA NI; VACCINE PRODUCTION; VIRUS CHARACTERIZATION; VIRUS LIKE AGENT; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; ENTEROVIRUS; ENTEROVIRUS A; GENETICS; HAND, FOOT AND MOUTH DISEASE; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR MIMICRY; RABBIT; SF9 CELL LINE; SPODOPTERA; TEMPERATURE; VIRION; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; ENTEROVIRUS; ENTEROVIRUS A, HUMAN; HAND, FOOT AND MOUTH DISEASE; HUMANS; MOLECULAR MIMICRY; RABBITS; SF9 CELLS; SPODOPTERA; TEMPERATURE; VACCINES, VIRUS-LIKE PARTICLE; VIRAL VACCINES; VIRION;

EID: 84957438394     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2015.09.023     Document Type: Article

References (37)

1. Solomon T., Lewthwaite P., Perera D., Cardosa M.J., McMinn P., Ooi M.H. Lancet Infect. Dis. 2010, 10:778-790.
2. Mao Q., Wang Y., Yao X., Bian L., Wu X., Xu M., Liang Z. Hum. Vaccines Immunother. 2014, 10:360-367.
3. Yip C.C.Y., Lau S.K.P., Woo P.C.Y., Yuen K.-Y. Emerg. Health Threats J. 2013, 6. incl Supplements, (2013).
4. Liu W., Wu S., Xiong Y., Li T., Wen Z., Yan M., Qin K., Liu Y., Wu J. PLoS One 2014, 9:e96051.
5. Xu W., Liu C.-F., Yan L., Li J.-J., Wang L.-J., Qi Y., Cheng R.-B., Xiong X.-Y. Virol. J. 2012, 9:8.
6. Kirnbauer R., Booy F., Cheng N., Lowy D.R., Schiller J.T. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:12180-12184.
7. Valenzuela P., Medina A., Rutter W.J., Ammerer G., Hall B.D. Nature 1982, 298:347-350.
8. Zhu F.C., Zhang J., Zhang X.F., Zhou C., Wang Z.Z., Huang S.J., Wang H., Yang C.L., Jiang H.M., Cai J.P., Wang Y.J., Ai X., Hu Y.M., Tang Q., Yao X., Yan Q., Xian Y.L., Wu T., Li Y.M., Miao J., Ng M.H., Shih J.W., Xia N.S. Lancet 2010, 376:895-902.
9. Zhao Q., Li S., Yu H., Xia N., Modis Y. Trends Biotechnol. 2013, 31:654-663.
10. Somasundaram B., Lua L.H.L. Pharm. Bioprocess. 2015, 3:45-59.
11. Stanway G. J. Gen. Virol. 1990, 71(Pt. 11):2483-2501.
12. Hu Y.C., Hsu J.T.A., Huang J.H., Ho M.S., Ho Y.C. Biotechnol. Lett. 2003, 25:919-925.
13. Cox M.M. Vaccine 2012, 30:1759-1766.
14. Palomares L.A., Mena J.A., Ramírez O.T. Methods 2012, 56:389-395.
15. Palomares L.A., Ramírez O.T. Biochem. Eng. J. 2009, 45:158-167.
16. Lua L.H.L., Connors N.K., Sainsbury F., Chuan Y.P., Wibowo N., Middelberg A.P.J. Biotechnol. Bioeng. 2014, 111:425-440.
17. Janakiraman V., Forrest W.F., Seshagiri S. Nat. Protoc. 2006, 1:2271-2276.
18. Chuan Y.P., Fan Y.Y., Lua L., Middelberg A.P.J. Biotechnol. Bioeng. 2008, 99:1425-1433.
19. Hink W.F., Thomsen D.R., Davidson D.J., Meyer A.L., Castellino F.J. Biotechnol. Prog. 1991, 7:9-14.
20. Chung C.Y., Chen C.Y., Lin S.Y., Chung Y.C., Chiu H.Y., Chi W.K., Lin Y.L., Chiang B.L., Chen W.J., Hu Y.C. Vaccine 2010, 28:6951-6957.
21. Possee R.D. Curr. Opin. Biotechnol. 1997, 8:569-572.
22. Naggie S., Bentley W.E. Biotechnol. Prog. 1998, 14:227-232.
23. Cruz P.E., Martins P.C., Alves P.M., Peixoto C.C., Santos H., Moreira J.L., Carrondo M.J.T. Biotechnol. Bioeng. 1999, 65:133-143.
24. Donaldson M., Wood H.A., Kulakosky P.C., Shuler M.L. Biotechnol. Bioeng. 1999, 63:255-262.
25. Cain K.D., Byrne K.M., Brassfield A.L., LaPatra S.E., Ristow S.S. Dis. Aquat. Organ. 1999, 36:1-10.
26. Gotoh T., Chiba K., Kikuchi K.-I. Biochem. Eng. J. 2004, 17:71-78.
27. Andersen J.N., Sriram P.G., Kalogerakis N., Behie L.A. Can. J. Chem. Eng. 1996, 74:511-517.
28. Kool M., Voncken J.W., Van Lier F.L.J., Tramper J., Vlak J.M. Virology 1991, 183:739-746.
29. Krell P. Cytotechnology 1996, 20:125-137.
30. Kumar S., Miller L.K. Virus Res. 1987, 7:335-349.
31. Jorio H., Tran R., Kamen A. Biotechnol. Prog. 2006, 22:319-325.
32. Chung Y.C., Ho M.S., Wu J.C., Chen W.J., Huang J.H., Chou S.T., Hu Y.C. Vaccine 2008, 26:1855-1862.
33. Liu Q.W., Yan K.X., Feng Y.F., Huang X.L., Ku Z.Q., Cai Y.C., Liu F., Shi J.P., Huang Z. Vaccine 2012, 30:6642-6648.
34. Gong M., Zhu H., Zhou J., Yang C., Feng J., Huang X., Ji G., Xu H., Zhu P. J. Virol. 2014.
35. Middelberg A.P.J. Biopharmaceutical Production Technology 2012, 79-105. Wiley-VCH Verlag GmbH & Co. KGaA.
36. Roldao A., Mellado M.C.M., Castilho L.R., Carrondo M.J.T., Alves P.M. Expert Rev. Vaccin. 2010, 9:1149-1176.
37. Lin S.Y., Chung Y.C., Chiu H.Y., Chi W.K., Chiang B.L., Hu Y.C. J. Biosci. Bioeng. 2014, 117:366-371.